Evelo Biosciences, Inc. (EVLO)

Evelo Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	0	140	321	477	130	285
Market Cap Growth	-69.82%	-56.30%	-32.71%	267.02%	-54.30%	375.50%
Enterprise Value	17	144	309	448	72	149
PE Ratio	-	-1.23	-2.63	-5.10	-1.52	-5.28
PB Ratio	-2.55	-28.11	37.06	15.66	2.16	2.08
P/FCF Ratio	-0.92	-1.38	-3.27	-6.42	-1.73	-5.40
P/OCF Ratio	-0.92	-1.39	-3.32	-6.53	-1.81	-6.02
EV/EBITDA Ratio	-1.15	-1.32	-2.69	-4.88	-0.83	-2.56
EV/EBIT Ratio	-1.13	-1.30	-2.64	-4.78	-0.82	-2.48
EV/FCF Ratio	-1.15	-1.41	-3.15	-6.03	-0.96	-2.82
Debt / Equity Ratio	-1.27	-10.24	6.50	1.37	0.33	0.09
Debt / EBITDA Ratio	-0.46	-0.47	-0.49	-0.44	-0.23	-0.21
Debt / FCF Ratio	-0.46	-0.50	-0.57	-0.54	-0.26	-0.23
Quick Ratio	0.43	3.87	3.94	3.47	7.99	21.95
Current Ratio	0.48	4.16	4.09	3.47	7.99	16.02
Interest Coverage	9.62	-23.22	-31.95	43.57	-82.32	-37.17
Return on Equity (ROE)	308.34%	2294.21%	-1409.67%	-307.25%	-142.30%	-39.32%
Return on Assets (ROA)	-399.23%	-177.72%	-139.04%	-103.34%	-94.22%	-33.69%
Return on Capital (ROIC)	-1059.85%	-235.05%	-177.64%	-130.29%	-108.17%	-38.93%
Earnings Yield	-4338724.97%	-81.61%	-38.04%	-19.62%	-65.87%	-18.93%
FCF Yield	-3898208.64%	-72.58%	-30.59%	-15.58%	-57.68%	-18.54%
Buyback Yield / Dilution	-221.78%	-64.75%	-34.02%	-23.25%	-46.46%	-483.10%
Total Shareholder Return	-221.78%	-64.75%	-34.02%	-23.25%	-46.46%	-483.10%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.